Enanta Pharmaceuticals
ENTA
#8009
Rank
NZ$0.33 B
Marketcap
$15.88
Share price
2.53%
Change (1 day)
-3.55%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2024 (TTM): -NZ$0.18 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are NZ$71.96 Million. In 2023 the company made an earning of -NZ$0.22 Billion a decrease over its 2022 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.18 Billion-19.56%
2023 -NZ$0.22 Billion4.39%
2022 -NZ$0.21 Billion-4.4%
2021 -NZ$0.22 Billion91.12%
2020 -NZ$0.12 Billion-407.13%
2019 NZ$37.11 M-78.63%
2018 NZ$0.17 B117.97%
2017 NZ$79.68 M-574.65%
2016 -NZ$16.79 Million-110.83%
2015 NZ$0.15 B-4.5%
2014 NZ$0.16 B-638.53%
2013 -NZ$30.15 Million-137.98%
2012 NZ$79.37 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$12.05 B-6,727.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.38 B-17,354.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.43 B-340.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$28.13 B-15,567.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$11.74 Billion 6,353.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.72 B-12,042.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland